In conclusion, METTL9 plays a crucial role in regulating the balance between the adipogenic and osteogenic differentiation of MSCs in osteoporosis, and thus, it is a potential target for the diagnosis and treatment of osteoporosis. The gene discussed is METTL9; the disease is osteoporosis.